REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/26/2026
Back to search
Official data from USPTO
NORMOTIM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
01/27/2026
Trademark type
Combined
Nice classes
5
Filing date
05/20/2020
Registration date
01/26/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/26/2021
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
US
Examiner
DELGIZZI, RONALD ERNEST
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of eight Cyrillic alphabet characters located above the term "NORMOTIM", wherein the Cyrillic characters represent an invented word, transliterated as "NORMOTIM" written in Latin characters.
Holders and representatives
Holders
Normopharm Inc.
Limited liability company "NORMOPHARM"
Representatives
Michael G Shariff INVENTA CAPITAL PLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary supplements; medicines used for the treatment of mental health and for the treatment and prevention of mental diseasesmood disordersanxiety disorderseating disordersstress related disorderstrauma-related disorders and conditions
Publications
History of USPTO decisions and trademark events.
24 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/04/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/09/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/03/2021
FIMP
FINAL DISPOSITION PROCESSED
05/03/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2020
PUBO
PUBLISHED FOR OPPOSITION
11/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2020
RFNT
REFUSAL PROCESSED BY IB
10/19/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/30/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/30/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/25/2020
RFRR
REFUSAL PROCESSED BY MPU
09/24/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/27/2020
CNRT
NON-FINAL ACTION WRITTEN
08/26/2020
DOCK
ASSIGNED TO EXAMINER
08/18/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/14/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/13/2020
Continuous trademark protection
Get notified about every new filing that threatens NORMOTIM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.